📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Quanticel

1.1 - Company Overview

Quanticel Logo

Quanticel

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of oncology drug discovery, leveraging a proprietary single-cell genomic analysis platform for human cancer to enable the discovery and development of breakthrough, first-in-class cancer therapeutics.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Quanticel

Good Therapeutics Logo

Good Therapeutics

HQ: United States Website
  • Description: Provider of self-regulating, context-dependent protein therapeutics that sense biomarkers and activate in the tumor microenvironment. Portfolio includes ATP-IFNα, ATP-IL12, PD1-IL12, LAG3-IL2, LRRC15-IFNα, and LRRC15-antiTGFβR2, designed to drive anti-tumor immunity, deliver IL-12 while blocking PD-1/PD-L1 signaling, target cancer-associated fibroblasts, and minimize systemic toxicity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Good Therapeutics company profile →
ViraTherapeutics Logo

ViraTherapeutics

HQ: Austria Website
  • Description: Provider of oncolytic virus-based anti-cancer therapeutics, including VSV-GP, a modified Vesicular Stomatitis Virus designed to selectively destroy cancer cells while sparing normal tissues. Offers preclinical safety and efficacy studies for VSV-GP and plans clinical trials to evaluate its therapeutic potential in cancer patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ViraTherapeutics company profile →
Tuhura Biosciences Logo

Tuhura Biosciences

HQ: United States Website
  • Description: Provider of phase 3 registration-stage immuno-oncology therapies, including personalized cancer vaccines (IFx-2.0 intratumoral pDNA expressing a bacterial protein; IFx-3.0 IV emm55 mRNA targeting CD22 for blood-related cancers) and MDSC-targeting bi-functional antibody drug conjugates (TBS-2025 Nal-anti TIGIT) to modulate immunosuppression, deliver a checkpoint inhibitor or T cell activator, and counter resistance to immunotherapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tuhura Biosciences company profile →
Trethera Logo

Trethera

HQ: United States Website
  • Description: Provider of small-molecule therapeutics that control DNA replication and integrity, including TRE-515, an orally bioavailable inhibitor of deoxycytidine kinase (dCK) targeting the nucleotide salvage pathway to treat solid tumors and autoimmune diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Trethera company profile →
F-star Logo

F-star

HQ: United Kingdom Website
  • Description: Provider of novel bispecific antibody therapeutics focused on immuno-oncology and oncology, developing bispecific antibody products to improve the standard of care, with the ability to create and develop Fcab™ antibody fragments.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full F-star company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Quanticel

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Quanticel

2.2 - Growth funds investing in similar companies to Quanticel

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Quanticel

4.2 - Public trading comparable groups for Quanticel

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Quanticel

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Quanticel

What does Quanticel do?

Quanticel is a provider of oncology drug discovery, leveraging a proprietary single-cell genomic analysis platform for human cancer to enable the discovery and development of breakthrough, first-in-class cancer therapeutics.

Who are Quanticel's competitors?

Quanticel's competitors and similar companies include Good Therapeutics, ViraTherapeutics, Tuhura Biosciences, Trethera, and F-star.

Where is Quanticel headquartered?

Quanticel is headquartered in United States.

How many employees does Quanticel have?

Quanticel has 1,000 employees 🔒.

When was Quanticel founded?

Quanticel was founded in 2010 🔒.

What sector and industry vertical is Quanticel in?

Quanticel is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Quanticel

Who are the top strategic acquirers in Quanticel's sector and industry

Top strategic M&A buyers and acquirers in Quanticel's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Quanticel?

Top strategic M&A buyers groups and sectors for Quanticel include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Quanticel's sector and industry vertical

Which are the top PE firms investing in Quanticel's sector and industry vertical?

Top PE firms investing in Quanticel's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Quanticel's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Quanticel's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Quanticel's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Quanticel include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Quanticel's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Quanticel?

The key public trading comparables and valuation benchmarks for Quanticel include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Quanticel for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Quanticel with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Quanticel's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Quanticel with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Quanticel's' sector and industry vertical?

Access recent funding rounds and capital raises in Quanticel's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Quanticel